Correlation Between KB Financial and Blueprint Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both KB Financial and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KB Financial and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KB Financial Group and Blueprint Medicines Corp, you can compare the effects of market volatilities on KB Financial and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KB Financial with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of KB Financial and Blueprint Medicines.

Diversification Opportunities for KB Financial and Blueprint Medicines

0.92
  Correlation Coefficient

Almost no diversification

The 3 months correlation between KB Financial and Blueprint is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding KB Financial Group and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and KB Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KB Financial Group are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of KB Financial i.e., KB Financial and Blueprint Medicines go up and down completely randomly.

Pair Corralation between KB Financial and Blueprint Medicines

Allowing for the 90-day total investment horizon KB Financial is expected to generate 1.23 times less return on investment than Blueprint Medicines. But when comparing it to its historical volatility, KB Financial Group is 1.63 times less risky than Blueprint Medicines. It trades about 0.24 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  8,851  in Blueprint Medicines Corp on April 27, 2025 and sell it today you would earn a total of  4,095  from holding Blueprint Medicines Corp or generate 46.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy91.94%
ValuesDaily Returns

KB Financial Group  vs.  Blueprint Medicines Corp

 Performance 
       Timeline  
KB Financial Group 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in KB Financial Group are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental drivers, KB Financial sustained solid returns over the last few months and may actually be approaching a breakup point.
Blueprint Medicines Corp 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Blueprint Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

KB Financial and Blueprint Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with KB Financial and Blueprint Medicines

The main advantage of trading using opposite KB Financial and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KB Financial position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.
The idea behind KB Financial Group and Blueprint Medicines Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Directory
Find actively traded commodities issued by global exchanges